DE69132682T2 - Zellwachstumsinhibitoren - Google Patents

Zellwachstumsinhibitoren

Info

Publication number
DE69132682T2
DE69132682T2 DE69132682T DE69132682T DE69132682T2 DE 69132682 T2 DE69132682 T2 DE 69132682T2 DE 69132682 T DE69132682 T DE 69132682T DE 69132682 T DE69132682 T DE 69132682T DE 69132682 T2 DE69132682 T2 DE 69132682T2
Authority
DE
Germany
Prior art keywords
pct
gbp
cell growth
sec
show
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69132682T
Other languages
English (en)
Other versions
DE69132682D1 (de
Inventor
Livio Mallucci
Valerie Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69132682D1 publication Critical patent/DE69132682D1/de
Publication of DE69132682T2 publication Critical patent/DE69132682T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69132682T 1990-11-02 1991-10-30 Zellwachstumsinhibitoren Expired - Fee Related DE69132682T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909023907A GB9023907D0 (en) 1990-11-02 1990-11-02 Cell growth inhibitors
PCT/GB1991/001898 WO1992007938A1 (en) 1990-11-02 1991-10-30 Cell growth inhibitors

Publications (2)

Publication Number Publication Date
DE69132682D1 DE69132682D1 (de) 2001-09-13
DE69132682T2 true DE69132682T2 (de) 2002-07-04

Family

ID=10684796

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69132682T Expired - Fee Related DE69132682T2 (de) 1990-11-02 1991-10-30 Zellwachstumsinhibitoren

Country Status (11)

Country Link
US (1) US6127169A (de)
EP (1) EP0555286B1 (de)
JP (1) JP3497504B2 (de)
AT (1) ATE204018T1 (de)
AU (1) AU650066B2 (de)
CA (1) CA2095335C (de)
DE (1) DE69132682T2 (de)
GB (2) GB9023907D0 (de)
IE (1) IE913816A1 (de)
IL (1) IL99940A0 (de)
WO (1) WO1992007938A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134443A1 (en) * 1992-04-27 1993-11-11 Terry C. Johnson Inhibitory factor
US5916871A (en) * 1992-04-27 1999-06-29 Kansas State University Research Foundation Inhibitory factor
AU9301998A (en) * 1997-09-05 1999-03-22 Board Of Regents Of The University Of Oklahoma, The Composition and methods using galectin-1
US5948628A (en) 1997-09-05 1999-09-07 The Board Of Regents Of The University Of Oklahoma Methods of screening for compounds which mimic galectin-1
JP2002322082A (ja) * 2001-04-26 2002-11-08 Purotejiin:Kk 腎炎の予防・治療剤
US7994113B2 (en) 2007-06-14 2011-08-09 Livio Mallucci βGBP, compositions comprising βGBP, and related methods and uses thereof
GB2450146A (en) * 2007-06-14 2008-12-17 Livio Mallucci ßGBP, compositions comprising ßGBP, and related methods and uses thereof
CN101679801A (zh) * 2007-06-15 2010-03-24 巴斯夫欧洲公司 低voc水性杂化粘合剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63164895A (ja) * 1986-09-13 1988-07-08 Sanwa Kagaku Kenkyusho Co Ltd 培養細胞由来のレクチン様蛋白質及びその製法並びに該物質を主成分とする抗腫瘍剤
ATE165980T1 (de) * 1987-08-20 1998-05-15 Childrens Medical Center Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
JP2983224B2 (ja) * 1988-04-14 1999-11-29 インサイト ファーマシューティカルズ，インコーポレイテッド 哺乳動物の１４―β―ｇａ１レクチン類

Also Published As

Publication number Publication date
WO1992007938A1 (en) 1992-05-14
EP0555286A1 (de) 1993-08-18
GB2249312A (en) 1992-05-06
JPH06502302A (ja) 1994-03-17
JP3497504B2 (ja) 2004-02-16
CA2095335C (en) 2002-10-22
DE69132682D1 (de) 2001-09-13
IE913816A1 (en) 1992-05-22
GB2249312B (en) 1994-11-16
ATE204018T1 (de) 2001-08-15
CA2095335A1 (en) 1992-05-03
GB9123036D0 (en) 1991-12-18
AU8756591A (en) 1992-05-26
EP0555286B1 (de) 2001-08-08
US6127169A (en) 2000-10-03
IL99940A0 (en) 1992-08-18
GB9023907D0 (en) 1990-12-12
AU650066B2 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
DE69434808D1 (de) Adenoviren mit veränderten faserproteinen
PL309225A1 (en) Pharmacologically active derivatives of pyridine and methods of obtaining them
HUP0104717A2 (hu) Készítmények és eljárások petefészekrák terápiájára és diagnózisára
BR0206985A (pt) Anticorpos modificados e métodos de uso
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
DK0751781T3 (da) Anvendelse af monoklonale antistoffer eller oplöselige oligomere ligander til fremstillingen af et medikament til forebyggelse eller behandling af neoplastiske sygdomme
ATE189527T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
DE69131699T2 (de) Verändertes menschliches iL-6
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
DK0837935T3 (da) Den 3'-ikke-translaterede region af det humane prohibitin-gen
DE69132682D1 (de) Zellwachstumsinhibitoren
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
HUT77289A (hu) Az N-terminálison szulfonil- vagy szulfamoil-csoportokat tartalmazó dipeptid-(p-amido-benzil)-amidok
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
FI942442A (fi) Proteiinien tuotto 7B2-proteiinia käyttäen
ES2179204T3 (es) Hidrazinas 2-aminocarbonil-1,2-bis(metilsulfonil)-1-sustituidas antitumorales.
SE9402880D0 (sv) New peptide derivatives
DK0841939T3 (da) Terapeutiske midler og autoimmune sygdomme
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
ES2062502T3 (es) Una proteina de factor i pura y un procedimiento para obtener dicha proteina.
DK0580782T3 (da) Anti-HIV-protein, TAP 29, fra Trichosanthes, DNA, som koder derfor, og terapeutiske anvendelser deraf
AU5870298A (en) 1,4-dihydropyridin derivatives and their use in therapy
ATE271878T1 (de) Verwendung von protein h als zytostattischer wirkstoff
Lgvignac General Announcements

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GOETZ, G., DIPL.-ING., PAT.-ANW., 97080 WUERZBURG

8339 Ceased/non-payment of the annual fee